David M. Kent

17.9k total citations · 4 hit papers
268 papers, 11.4k citations indexed

About

David M. Kent is a scholar working on Economics and Econometrics, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David M. Kent has authored 268 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Economics and Econometrics, 66 papers in Epidemiology and 62 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David M. Kent's work include Health Systems, Economic Evaluations, Quality of Life (59 papers), Acute Ischemic Stroke Management (36 papers) and Cardiovascular and Diving-Related Complications (28 papers). David M. Kent is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (59 papers), Acute Ischemic Stroke Management (36 papers) and Cardiovascular and Diving-Related Complications (28 papers). David M. Kent collaborates with scholars based in United States, Netherlands and United Kingdom. David M. Kent's co-authors include Rodney A. Hayward, David E. Thaler, Ewout W. Steyerberg, David van Klaveren, Robin Ruthazer, John B. Wong, Alawi Alsheikh‐Ali, Harry P. Selker, Thomas A Trikalinos and Jessica K. Paulus and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

David M. Kent

260 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis

2015 453 citations David M. Kent, John B. Wong et al. Annals of Internal Medicine profile →
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke

2013 379 citations David M. Kent, Robin Ruthazer et al. profile →
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects

2018 258 citations David M. Kent, Ewout W. Steyerberg et al. profile →
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

2019 220 citations David M. Kent, Jessica K. Paulus et al. Annals of Internal Medicine profile →

Peers

Countries citing papers authored by David M. Kent

Since Specialization

Citations

This map shows the geographic impact of David M. Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Kent more than expected).

Fields of papers citing papers by David M. Kent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Kent. The network helps show where David M. Kent may publish in the future.

Co-authorship network of co-authors of David M. Kent

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Kent. A scholar is included among the top collaborators of David M. Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Kent. David M. Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk 2025 ·Journal of the American Heart Association ·Yihong Deng, Eric C. Polley, Jeph Herrin, (unknown), David M. Kent, Joseph S. Ross, Bradley A. Maron, (unknown), Rozalina G. McCoy	1
2	A Framework for Considering the Value of Race and Ethnicity in Estimating Disease Risk 2024 ·Annals of Internal Medicine ·(unknown), Soroush Saghafian, David M. Kent, Sharad Goel	6
3	Management of covert brain infarction survey: A call to care for and trial this neglected population 2023 ·European Stroke Journal ·Thomas R. Meinel, (unknown), Johannes Kaesmacher, Adnan Mujanović, Marco Pasi, Lester Y. Leung, David M. Kent, Yi Sui, David Seiffge, Philipp Bücke, Roza M. Umarova, Marcel Arnold, Laurent Roten, Thanh N. Nguyen, Joanna M. Wardlaw, Urs Fischer	5
4	Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial 2023 ·PLoS ONE ·(unknown), Geert‐Jan Geersing, (unknown), Martin E W Hemels, Michiel Rienstra, Isabelle C. Van Gelder, Maarten van Smeden, David van Klaveren, David M. Kent, Frans H. Rutten, Sander van Doorn	9
5	A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases 2023 ·npj Digital Medicine ·(unknown), David van Klaveren, Patrick Ryan, Ewout W. Steyerberg, David M. Kent, Peter R. Rijnbeek	7
6	Systematic metareview of prediction studies demonstrates stable trends in bias and low PROBAST inter-rater agreement 2023 ·Journal of Clinical Epidemiology ·(unknown), Roemer J. Janse, Esmée Venema, David M. Kent, Merel van Diepen, Friedo W. Dekker, Ewout W. Steyerberg, Ype de Jong	7
7	Development and validation of self-monitoring auto-updating prognostic models of survival for hospitalized COVID-19 patients 2022 ·Nature Communications ·Todd Levy, Kevin Coppa, (unknown), Douglas P. Barnaby, Marc d. Paradis, Stuart L. Cohen, (unknown), David van Klaveren, David M. Kent, Karina W. Davidson, Jamie S. Hirsch, Theodoros P. Zanos	11
8	Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation 2022 ·Journal of the American Heart Association ·Peter A. Noseworthy, Holly K. Van Houten, Harlan M. Krumholz, David M. Kent, Neena S. Abraham, Jonathan Graff‐Radford, Mohamad Alkhouli, Henry J. Henk, Nilay D. Shah, Bernard J. Gersh, Paul A. Friedman, David R. Holmes, Xiaoxi Yao	15
9	Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort 2022 ·Annals of Neurology ·David M. Kent, Lester Y. Leung, (unknown), Andy Wang, Patrick H. Luetmer, David F. Kallmes, Jason Nelson, Sunyang Fu, Chengyi Zheng, Ellen M. Vickery, Hongfang Liu, Alastair J. Noyce, Wansu Chen	4
10	Association of Incidentally Discovered Covert Cerebrovascular Disease Identified Using Natural Language Processing and Future Dementia 2022 ·Journal of the American Heart Association ·David M. Kent, Lester Y. Leung, Yichen Zhou, Patrick H. Luetmer, David F. Kallmes, Jason Nelson, Sunyang Fu, (unknown), Chengyi Zheng, Hongfang Liu, Wansu Chen	10
11	External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature 2021 ·Circulation Cardiovascular Quality and Outcomes ·Benjamin S. Wessler, Jason Nelson, (unknown), (unknown), Gaurav Gulati, (unknown), Ben Van Calster, David van Klaveren, Esmée Venema, Ewout W. Steyerberg, Jessica K. Paulus, David M. Kent	39
12	COVID outcome prediction in the emergency department (COPE): using retrospective Dutch hospital data to develop simple and valid models for predicting mortality and need for intensive care unit admission in patients who present at the emergency department with suspected COVID-19 2021 ·BMJ Open ·David van Klaveren, (unknown), Jelmer Alsma, (unknown), (unknown), Marlijn J. A. Kamps, Tom Dormans, (unknown), (unknown), (unknown), (unknown), Hilde R.H. de Geus, Rozemarijn L van Bruchem-Visser, Jelle Miedema, Annelies Verbon, Els van Nood, David M. Kent, Stephanie C. E. Schuit, Hester F. Lingsma	9
13	Predictive approaches to heterogeneous treatment effects: a systematic review 2019 ·medRxiv ·(unknown), Jessica K. Paulus, Gowri Raman, John B. Wong, Ewout W. Steyerberg, Peter R. Rijnbeek, David M. Kent, David van Klaveren	0
14	Natural Language Processing for the Identification of Silent Brain Infarcts From Neuroimaging Reports 2019 ·JMIR Medical Informatics ·Sunyang Fu, Lester Y. Leung, Yanshan Wang, (unknown), David F. Kallmes, (unknown), (unknown), Michael Clark, Patrick H. Luetmer, Paul Kingsbury, David M. Kent, Hongfang Liu	35
15	Untapped potential of multicenter studies: a review of cardiovascular risk prediction models revealed inappropriate analyses and wide variation in reporting 2019 ·SHILAP Revista de lepidopterología ·Laure Wynants, David M. Kent, D. Timmerman, Christine Lundquist, Ben Van Calster	28
16	Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders 2016 ·Clinical Lymphoma Myeloma & Leukemia ·Aaron S. Rosenberg, Robin Ruthazer, Jessica K. Paulus, David M. Kent, Andrew M. Evens, Andreas K. Klein	13
17	Evidence of Systematic Duplication by New Percutaneous Coronary Intervention Programs 2013 ·Circulation Cardiovascular Quality and Outcomes ·Thomas W. Concannon, Jason Nelson, David M. Kent, John L. Griffith	38
18	Assessing historical and future runoff modelled using rainfall from the analogue downscaling method 2011 ·Chan, F., Marinova, D. and Anderssen, R.S. (eds) MODSIM2011, 19th International Congress on Modelling and Simulation. ·Jin Teng, Francis H. S. Chiew, Bertrand Timbal, Jai Vaze, Yang Wang, Bill Wang, (unknown), David M. Kent, Dewi Kirono, David Post, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
19	Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke 2004 ·Stroke ·David M. Kent, Lori Lyn Price, Peter A. Ringleb, Michael D. Hill, Harry P. Selker	181
20	Predicting Nursing Home Admission 2004 ·Alzheimer Disease & Associated Disorders ·Jane Banaszak‐Holl, A. Mark Fendrick, Norman L. Foster, A. Regula Herzog, Mohammed U. Kabeto, David M. Kent, Walter L. Straus, Kenneth M. Langa	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact